Market News Archives

Meta’s $10 Billion Indiana Data Bet: When AI Meets the Corn Belt -( $META )

by John F. Heerdink, Jr. February 12, 2026 632Views 0Likes

Meta’s decision to plant a more-than-1-gigawatt data center in Lebanon, Indiana, reads like a statement that the future of AI won’t be confined to Silicon Valley ZIP codes. The planned campus, with over $10 billion in investment, is set to become one…

AST SpaceMobile Reaches for the Stars—and a Billion Dollars—With Convertible Notes -( $ASTS )

by John F. Heerdink, Jr. February 12, 2026 536Views 0Likes

AST SpaceMobile (ASTS) is dialing up its next phase of growth with a $1.0 billion private offering of convertible senior notes due 2036, aiming to finance a truly out-of-this-world ambition: building the first space-based cellular broadband network directly accessible by standard smartphones.…

Stock Market Today: Strong Jobs Report Leaves Wall Street Flat – February 11, 2026

by John F. Heerdink, Jr. February 12, 2026 381Views 0Likes

Wall Street finished Wednesday essentially unchanged, as a hotter‑than‑expected January jobs report lifted Treasury yields and tempered hopes for imminent Fed rate cuts, leaving the major indexes little moved by the close. in Index performance Dow Jones Industrial Average: Fell roughly 70…

U.S. Stocks Propel Forward On Monday – February 9, 2026 -( $AVGO $DV $FLYX $META $NOK $NVDA $OKLO $OPEN $ORCL $PLTR $RIO $TSLA $TSM Rise!)

by John F. Heerdink, Jr. February 10, 2026 5950Views 0Likes

US stocks extended last week’s relief rally on Monday, with megacap tech doing most of the heavy lifting while value names tried to remember what outperformance felt like. Investors spent the session toggling between AI euphoria, tariff anxiety and a yield curve…

Eupraxia Pharmaceuticals: Injecting New Life Into EoE — One Microsphere at a Time -( $EPRX $SNY $XBI )

by John F. Heerdink, Jr. February 9, 2026 572Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX) may still wear the “clinical-stage” name tag, but its stock has been behaving like it already found a seat at the grown‑ups’ table on Wall Street. Over the past year, shares have climbed roughly 160%, far outpacing the…

Eli Lilly’s Weight-Loss Empire Just Got Heavier with $2.4B Acquisition – And So Did Its Market Cap -( $LLY $NVO $SPY )

by John F. Heerdink, Jr. February 9, 2026 544Views 0Likes

Eli Lilly (LLY) has once again muscled its way to the top of the healthcare league tables, with its stock climbing as investors double down on the idea that obesity drugs are less a fad and more a new asset class. The…

Dow Breaks 50,000 as Wall Street Limps, Then Leaps Into the Weekend – February 6, 2026 -( $DIA $EPRX $FLYX $LLY $MCD $MANE $MODD $NOK $RIO Rise!)

by John F. Heerdink, Jr. February 6, 2026 5875Views 0Likes

Wall Street closed the week ending Feb. 6, 2026 looking a bit like a trader after a rough options expiry: bruised, but suddenly energetic once the bell rang on Friday. The Dow finally cracked the 50,000 mark in a more-than-1,000‑point sprint, while…

Can Modular Medical Crack the “Almost‑Pumper” Code? Inside the Bull Case for MODD’s Pivot System -( $MODD $PODD $TNDM )

by John F. Heerdink, Jr. February 6, 2026 622Views 0Likes

Modular Medical’s (NASDAQ: MODD) Pivot insulin delivery system is quietly building a credible bull case that now extends beyond regulatory momentum and leadership credentials into hard operational execution. With the company achieving a key manufacturing milestone for its Pivot tubeless insulin patch…

Rotating, Not Crashing: What This 2026 Market Shake‑Up Signals for Investors -( $SPY $QQQ $DIA $VIX )

by John F. Heerdink, Jr. February 6, 2026 560Views 0Likes

Investors currently navigating choppy markets may feel like they accidentally signed up for the roller coaster instead of the scenic tour, but the underlying track still appears pointed in the right direction. Volatility Takes Center Stage In early February, major U.S. indexes…

Stock Market Trades Like a Slightly Over-Caffeinated & Negative Economist – February 5, 2026 -( $MODD $PAHC $VIX Rise!)

by John F. Heerdink, Jr. February 6, 2026 5732Views 0Likes

US stocks spent Thursday behaving like a slightly over-caffeinated, negative economist: plenty of motion & an overall negative conviction, as investors digested another wave of tech volatility, macro cross-currents, and a busy new-issue calendar heading into Friday’s jobs data. As evidence the…

Market News

Your Guide To Staying Informed In The Markets